REFERENC
[1] Patlolla S.H., Schaff H.V., Nishimura R.A., et al. Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation [J]. J Am Coll Cardiol, 2022, 80(24): 2289-98.
[2] Abe Y., Akamatsu K., Ito K., et al. Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients [J]. Circ J, 2018, 82(5): 1451-8.
[3] Offen S., Playford D., Strange G., et al. Adverse Prognostic Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from the National Echocardiography Database of Australia [J]. J Am Soc Echocardiogr, 2022, 35(8): 810-7.
[4] Wang N., Fulcher J., Abeysuriya N., et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis [J]. Eur Heart J, 2019, 40(5): 476-84.
[5] Soulat-Dufour L., Lang S., Addetia K., et al. Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation [J]. J Am Coll Cardiol, 2022, 79(10): 951-61.
[6] Marrouche N.F., Wazni O., Mcgann C., et al. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial [J]. JAMA, 2022, 327(23): 2296-305.
[7] Kistler P.M., Chieng D., Sugumar H., et al. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial [J]. JAMA, 2023, 329(2): 127-35.
[8] Baman J.R., Passman R.S. Atrial Fibrillation [J]. JAMA, 2021, 325(21): 2218.
[9] Jastrzebski M., Moskal P., Bednarek A., et al. His-bundle pacing as a standard approach in patients with permanent atrial fibrillation and bradycardia [J]. Pacing Clin Electrophysiol, 2018, 41(11): 1508-12.
[10] Clark D.M., Plumb V.J., Epstein A.E., et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation [J]. J Am Coll Cardiol, 1997, 30(4): 1039-45.
[11] Addetia K., Harb S.C., Hahn R.T., et al. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation [J]. JACC Cardiovasc Imaging, 2019, 12(4): 622-36.
[12] Moore S.K.L., Chau K.H., Chaudhary S., et al. Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patients [J]. Pacing Clin Electrophysiol, 2019, 42(5): 542-7.
[13] Beurskens N.E.G., Tjong F.V.Y., De Bruin-Bon R.H.A., et al. Impact of Leadless Pacemaker Therapy on Cardiac and Atrioventricular Valve Function Through 12 Months of Follow-Up [J]. Circ Arrhythm Electrophysiol, 2019, 12(5): e007124.
[14] Arkles J.S., Epstein A.E. Leadless Pacemakers and the Tricuspid Valve: Can You Believe It? Can This Be True? [J]. Circ Arrhythm Electrophysiol, 2019, 12(5): e007375.
[15] Jastrzebski M., Kielbasa G., Cano O., et al. Left bundle branch area pacing outcomes: the multicentre European MELOS study [J]. Eur Heart J, 2022, 43(40): 4161-73.
[16] Vahanian A., Beyersdorf F., Praz F., et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease [J]. Eur Heart J, 2022, 43(7): 561-632.
[17] Glikson M., Nielsen J.C., Kronborg M.B., et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy [J]. Eur Heart J, 2021, 42(35): 3427-520.
[18] Jiang Z., Chang Q., Wu Y., et al. Typical BBB morphology and implantation depth of 3830 electrode predict QRS correction by left bundle branch area pacing [J]. Pacing Clin Electrophysiol, 2020, 43(1): 110-7.
[19] Burri H., Jastrzebski M., Cano O., et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS) [J]. Europace, 2023, 25(4): 1208-36.
[20] Hindricks G., Potpara T., Dagres N., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC [J]. Eur Heart J, 2021, 42(5): 373-498.
[21] Zoghbi W.A., Adams D., Bonow R.O., et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance [J]. J Am Soc Echocardiogr, 2017, 30(4): 303-71.
[22] Naito M., David D., Michelson E.L., et al. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model [J]. Am Heart J, 1983, 106(2): 284-91.
[23] Stojadinovic P., Deshraju A., Wichterle D., et al. The hemodynamic effect of simulated atrial fibrillation on left ventricular function [J]. J Cardiovasc Electrophysiol, 2022, 33(12): 2569-77.
[24] Klein F.J., Bell S., Runte K.E., et al. Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept [J]. Am J Physiol Heart Circ Physiol, 2016, 311(4): H1031-H9.
[25] Silverman D.N., Rambod M., Lustgarten D.L., et al. Heart Rate-Induced Myocardial Ca(2+) Retention and Left Ventricular Volume Loss in Patients With Heart Failure With Preserved Ejection Fraction [J]. J Am Heart Assoc, 2020, 9(17): e017215.
[26] Wahlberg K., Arnold M.E., Lustgarten D., et al. Effects of a Higher Heart Rate on Quality of Life and Functional Capacity in Patients With Left Ventricular Diastolic Dysfunction [J]. Am J Cardiol, 2019, 124(7): 1069-75.
[27] Infeld M., Wahlberg K., Cicero J., et al. Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial [J]. JAMA Cardiol, 2023, 8(3): 213-21.
[28] Su L., Wang S., Wu S., et al. Long-Term Safety and Feasibility of Left Bundle Branch Pacing in a Large Single-Center Study [J]. Circ Arrhythm Electrophysiol, 2021, 14(2): e009261.
[29] Li X., Zhu H., Fan X., et al. Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing [J]. Heart Rhythm, 2022, 19(7): 1202-3.
[30] Hu Q., You H., Chen K., et al. Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: Effects on postoperative tricuspid regurgitation deterioration [J]. Heart Rhythm, 2023, 20(2): 217-23.
[31] Huang X., Lin M., Huang S., et al. Impact on right ventricular performance in patients undergoing permanent pacemaker implantation: Left bundle branch pacing versus right ventricular septum pacing [J]. J Cardiovasc Electrophysiol, 2022, 33(12): 2614-24.
[32] Heckman L.I.B., Luermans J., Curila K., et al. Comparing Ventricular Synchrony in Left Bundle Branch and Left Ventricular Septal Pacing in Pacemaker Patients [J]. J Clin Med, 2021, 10(4).
Figure 1. Severity of functional tricuspid regurgitation (FTR) in total patients (n=29) during follow up. * There was a significant difference compared to the baseline.